
VLY · Financial Services
The market is treating 2025's earnings improvement as proof the turnaround is complete, but the more important signal is that ROIC is still near zero — the acquired capital base is not earning adequate returns, and normalized credit costs haven't yet been stress-tested against a genuine slowdown in NY metro real estate.
$13.09
$6.00
A spread-lending machine caught in the awkward middle — too large for community intimacy, too small for technology dominance — with ROIC near zero after acquisitions that built scale without building quality. The moat exists but doesn't compound.
The Piotroski score of 4 and near-zero ROIC tell the same story: this bank is not earning its cost of capital, and cash conversion has become inconsistent enough to raise questions about whether reported earnings reflect real economic output. The balance sheet is patched, not healed.
The 2025 earnings rebound is real but narrow — normalization off a trough rather than evidence of a structurally stronger franchise. Management's guidance for NII growth and margin expansion is credible, but the burden of proof is high given that every prior growth narrative here was followed by a shareholder-funded correction.
Every DCF scenario, including the optimistic one, lands well below the current price — unusual because regional bank value is almost entirely captured by discounted cash flows, with little optionality to justify a premium. The market appears to be pricing in a CRE recovery and margin expansion that the underlying numbers have not yet earned.
The CRE book is the single most important variable, and it sits in markets — NY/NJ office and multifamily — where structural impairment from hybrid work may be permanent, not cyclical. The dual-CRO governance anomaly layered on top of that credit concentration is the kind of institutional ambiguity that tends to surface exactly when you need risk discipline most.
The investment case for Valley National requires believing that three things resolve simultaneously: the CRE credit cycle peaks and provisions normalize, net interest margin expands to the mid-3.30s, and the acquired balance sheet finally earns above the cost of capital for the first time in three years. None of those is implausible, but requiring all three to land on schedule is a heavy ask — and the current price appears to embed a substantial portion of that optimism already. The quality of the underlying franchise doesn't justify paying for a perfect execution scenario. The trajectory question is genuinely uncertain. Management's pivot back to CRE growth in 2026, specifically owner-occupied, signals confidence — but the same management team that funded aggressive CRE accumulation through back-to-back acquisitions is now returning to that same well. The organic recruiting push into Philadelphia, California, and Florida is strategically sensible, but geographic diversification takes years to meaningfully change credit concentration, and in the interim the NY/NJ office and multifamily exposure remains the dominant driver of credit outcomes. The single biggest risk is a CRE loss cycle that proves deeper and longer than consensus expects. NY metro office vacancy reflects a structural demand reduction from hybrid work, not a cyclical dip waiting to reverse. If collateral values keep eroding and workout timelines extend, the provision line expands, capital gets consumed, and management faces the same sequence it just completed — dilutive capital raise, dividend pressure, investor reset — all starting from a weaker reputation and a more skeptical shareholder base than the first time around.